Practical approaches to the treatment of social phobia.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001521:Behavior Therapy; D001549:Benzamides / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D015897:Comorbidity; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000453:epidemiology; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010624:Phenelzine / Q000627:therapeutic use; D010698:Phobic Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D015995:Prevalence
D000319:Adrenergic beta-Antagonists; D001549:Benzamides; D008996:Monoamine Oxidase Inhibitors; D005473:Fluoxetine; D016642:Bupropion; D001569:Benzodiazepines; D002998:Clonazepam; D010624:Phenelzine; D020912:Moclobemide